(E)-hex-3-enedioic acid;(E)-hex-3-enoic acid

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: (E)-hex-3-enedioic acid;(E)-hex-3-enoic acid
• 化学式: C12H18O6
• 分子量: 258.27
• InChiKey: AVHHAXUKBOWBCE-ZPDXYWESSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.92
• 重原子数：
  18
• 可旋转键数：
  7
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.42
• 拓扑面积：
  112
• 氢给体数：
  3
• 氢受体数：
  6

文献信息

• Glycitan Esters of Unsaturated Fatty Acids and Their Preparation
  申请人：Elevance Renewable Sciences, Inc.

  公开号：US20150307469A1

  公开（公告）日：2015-10-29

  A method is disclosed for making an unsaturated glycitan ester by reacting intramolecular condensates of glycitols having four or more carbons with a metathesis-derived unsaturated fatty acid in the presence of an alkaline catalyst and under conditions sufficient to form the aforesaid unsaturated glycitan fatty ester. A composition is also disclosed comprising a compound of the following structure: wherein R 1 is hydrogen, alkyl, aryl or (CH 2 ) 1-9 —COOR 5 ; wherein R 5 is wherein R 2 , R 3 and R 4 are hydrogen, or —(O)C—(CH 2 ) m —CH═CH—R 1 or —(CH 2 CH 2 O) n H or mixtures thereof; wherein m is 1 to 9; and wherein n is 1 to 100.

  本方法涉及通过在碱性催化剂存在下，在足够条件下与来自交换反应的不饱和脂肪酸反应的具有四个或更多碳的甘露醇的分子内缩合物反应，制备不饱和的甘露醇脂肪酸酯。本发明还涉及一种化合物，其结构如下：其中R1为氢、烷基、芳基或(CH2)1-9—COOR5；其中R5为其中R2、R3和R4为氢，或—(O)C—(CH2)m—CH═CH—R1或—(CH2CH2O)nH或它们的混合物；其中m为1至9；其中n为1至100。
• GLYCITAN ESTERS OF UNSATURATED FATTY ACIDS AND THEIR PREPARATION
  申请人：Elevance Renewable Sciences, Inc.

  公开号：EP2970169A1

  公开（公告）日：2016-01-20
• US20140275580A1
  申请人：——

  公开号：US20140275580A1

  公开（公告）日：2014-09-18
• US9045447B2
  申请人：——

  公开号：US9045447B2

  公开（公告）日：2015-06-02
• [EN] GLYCITAN ESTERS OF UNSATURATED FATTY ACIDS AND THEIR PREPARATION<br/>[FR] ESTERS DE GLYCITAN D'ACIDES GRAS INSATURÉS ET LEUR PRÉPARATION
  申请人：ELEVANCE RENEWABLE SCIENCES

  公开号：WO2014159226A1

  公开（公告）日：2014-10-02

  A method is disclosed for making an unsaturated glycitan ester by reacting intramolecular condensates of glycitols having four or more carbons with a metathesis-derived unsaturated fatty acid in the presence of an alkaline catalyst and under conditions sufficient to form the aforesaid unsaturated glycitan fatty ester. A composition is also disclosed including a compound of the following structure: wherein R1 is hydrogen, alkyl, aryl or (CH2)i.g-COOR5; wherein R5 is wherein R2, R3 and R4 are hydrogen, or -(0)C-(CH2)m-CH=CH-R1 or - (CH2CH20)nH or mixtures thereof; wherein m is 1 to 9; and wherein n is 1 to 100.